THE INNOVATIVE MEDICINES FUND OR THE IN NEED OF MEDICINES FUND: ANALYSIS OF NICE TECHNOLOGY APPRAISALS TO EXPLORE BARRIERS TO MANAGED ACCESS AGREEMENTS

被引：0
|
作者：
Orchard, M. [1 ]
机构：
[1] Cogentia, Cambridge, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA127
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 6 条
  • [1] THE IN NEED OF MEDICINES FUND: ANALYSIS OF NICE TECHNOLOGY APPRAISALS TO EXPLORE BARRIERS TO MANAGED ACCESS VIA THE IMF
    Orchard, M.
    Hale, G.
    VALUE IN HEALTH, 2023, 26 (12) : S345 - S346
  • [2] CHARACTERISATION OF MANAGED ACCESS AGREEMENTS UNDER THE NICE CANCER DRUGS FUND
    Hall, A.
    Macaulay, R.
    VALUE IN HEALTH, 2020, 23 : S69 - S69
  • [3] Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis
    McMullan, Patrick
    Ajay, Vamadevan S.
    Srinivas, Ravi
    Bhalla, Sandeep
    Prabhakaran, Dorairaj
    Banerjee, Amitava
    GLOBAL HEALTH ACTION, 2018, 11 (01)
  • [4] The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep?
    Angelis, Aris
    Aggarwal, Ajay
    Miners, Alec
    Grieve, Richard
    Cairns, John
    Briggs, Andrew
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2023, 116 (10) : 324 - 330
  • [5] Access to medicines in the United Kingdom: a document analysis regarding health technology assessment recommendations for innovative medicines (2017-2020)
    Abbas, Nasir
    Javid, Farideh
    Babar, Zaheer-Ud-Din
    DRUGS & THERAPY PERSPECTIVES, 2024, 40 (10) : 417 - 426
  • [6] Efficacy, Safety, and Economics of Innovative Medicines: The Role of Multi-Criteria Decision Analysis and Managed Entry Agreements in Practice and Policy
    Fens, Tanja
    van Puijenbroek, Eugene P.
    Postma, Maarten J.
    FRONTIERS IN MEDICAL TECHNOLOGY, 2021, 3
1